Figure 1.
Myelofibrosis-free survival curves. (A) Kaplan-Meier curves for MFS of patients categorized as CALR-low and CALR-high VAF (CALRm VAF <60% and ≥60%, respectively) are presented. (B) Kaplan-Meier curves for MFS are presented for patients with CALR-low and CALR-high, as well as patients with ET with JAK2V617F mutation, stratified by their VAF <35% or ≥35%, as in Guglielmelli et al9, and patients with TN. The significance levels for comparison of different patient cohorts are reported in the lower table.
